AU2003262789A8 - Abca13 nucleic acids and proteins, and uses thereof - Google Patents

Abca13 nucleic acids and proteins, and uses thereof

Info

Publication number
AU2003262789A8
AU2003262789A8 AU2003262789A AU2003262789A AU2003262789A8 AU 2003262789 A8 AU2003262789 A8 AU 2003262789A8 AU 2003262789 A AU2003262789 A AU 2003262789A AU 2003262789 A AU2003262789 A AU 2003262789A AU 2003262789 A8 AU2003262789 A8 AU 2003262789A8
Authority
AU
Australia
Prior art keywords
abca13
proteins
nucleic acids
nucleic
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003262789A
Other versions
AU2003262789A1 (en
Inventor
Tarmo Annilo
Marcia L Triunfol
Micheal C Dean
Isabelle Arnould-Reguigne
Catherine Prades
Marie-Francoise Rosier-Montus
Patrice Denefle
Sergey Shulenin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
US Department of Health and Human Services
Original Assignee
Aventis Pharma SA
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA, US Department of Health and Human Services filed Critical Aventis Pharma SA
Publication of AU2003262789A1 publication Critical patent/AU2003262789A1/en
Publication of AU2003262789A8 publication Critical patent/AU2003262789A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
AU2003262789A 2002-08-20 2003-08-19 Abca13 nucleic acids and proteins, and uses thereof Abandoned AU2003262789A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US40500602P 2002-08-20 2002-08-20
US60/405,006 2002-08-20
US45450203P 2003-03-12 2003-03-12
US60/454,502 2003-03-12
PCT/US2003/026335 WO2004018633A2 (en) 2002-08-20 2003-08-19 Abca13 nucleic acids and proteins, and uses thereof

Publications (2)

Publication Number Publication Date
AU2003262789A1 AU2003262789A1 (en) 2004-03-11
AU2003262789A8 true AU2003262789A8 (en) 2004-03-11

Family

ID=31949879

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003262789A Abandoned AU2003262789A1 (en) 2002-08-20 2003-08-19 Abca13 nucleic acids and proteins, and uses thereof

Country Status (2)

Country Link
AU (1) AU2003262789A1 (en)
WO (1) WO2004018633A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10522240B2 (en) 2006-05-03 2019-12-31 Population Bio, Inc. Evaluating genetic disorders
US7702468B2 (en) 2006-05-03 2010-04-20 Population Diagnostics, Inc. Evaluating genetic disorders
DK2601609T3 (en) 2010-08-02 2017-06-06 Population Bio Inc COMPOSITIONS AND METHODS FOR DISCOVERING MUTATIONS CAUSING GENETIC DISORDERS
EP2766483B1 (en) 2011-10-10 2022-03-23 The Hospital For Sick Children Methods and compositions for screening and treating developmental disorders
WO2013067451A2 (en) 2011-11-04 2013-05-10 Population Diagnostics Inc. Methods and compositions for diagnosing, prognosing, and treating neurological conditions
EP2812452B1 (en) 2012-02-09 2020-05-27 Population Bio, Inc. Methods and compositions for screening and treating developmental disorders
DK2895621T3 (en) 2012-09-14 2020-11-30 Population Bio Inc METHODS AND COMPOSITION FOR DIAGNOSIS, FORECAST AND TREATMENT OF NEUROLOGICAL CONDITIONS
WO2014052855A1 (en) * 2012-09-27 2014-04-03 Population Diagnostics, Inc. Methods and compositions for screening and treating developmental disorders
KR102383710B1 (en) * 2013-08-05 2022-04-08 이매틱스 바이오테크놀로지스 게엠베하 Novel immunotherapy against several tumors, such as lung cancer, including nsclc
TWI777195B (en) * 2013-08-05 2022-09-11 德商伊瑪提克斯生物科技有限公司 Novel peptides, cells, and their use against several tumors, methods for production thereof and pharmaceutical composition comprising the same
US10724096B2 (en) 2014-09-05 2020-07-28 Population Bio, Inc. Methods and compositions for inhibiting and treating neurological conditions
AU2016286364B2 (en) * 2015-06-30 2022-07-28 Ethris Gmbh ATP-binding cassette family coding polyribonucleotides and formulations thereof
US10240205B2 (en) 2017-02-03 2019-03-26 Population Bio, Inc. Methods for assessing risk of developing a viral disease using a genetic test
SI3625368T1 (en) 2018-08-08 2023-04-28 Pml Screening, Llc Methods for assessing the risk of developing progressive multifocal leukoencephalopathy caused by john cunningham virus by genetic testing

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555323B2 (en) * 2000-02-08 2003-04-29 Pfizer Inc. Assay for ABCA1
WO2001074836A1 (en) * 2000-03-31 2001-10-11 Hyseq, Inc. Novel bone marrow nucleic acids and polypeptides
EP1354039A2 (en) * 2000-11-28 2003-10-22 Amgen, Inc. Atp-binding cassette transporter-like molecules and uses thereof

Also Published As

Publication number Publication date
WO2004018633A2 (en) 2004-03-04
AU2003262789A1 (en) 2004-03-11
WO2004018633A3 (en) 2005-04-21

Similar Documents

Publication Publication Date Title
EP1556490A4 (en) Novel nucleic acids and polypeptides
EP1504099A4 (en) Novel nucleic acids and polypeptides
EP1432800A4 (en) Novel nucleic acids and polypeptides
EP1470238A4 (en) Novel nucleic acids and polypeptides
EP1427746A4 (en) Protein and nucleic acid expression systems
EP1430112A4 (en) Novel nucleic acids and polypeptides
EP1368475A4 (en) Novel nucleic acids and polypeptides
AU2003262789A8 (en) Abca13 nucleic acids and proteins, and uses thereof
EP1660016A4 (en) Sars nucleic acids, proteins, vaccines, and uses thereof
EP1383533A4 (en) Proteins and nucleic acids encoding same
EP1585760A4 (en) Btl-ii nucleic acids, proteins, and antibodies
AU2002250254A1 (en) Nucleic acids, proteins, and antibodies
AU2003235096A1 (en) Novel protein and dna thereof
IL161765A0 (en) P85-alpha nucleic acids, polypeptides and related methods
AU2003265635A8 (en) Nphp nucleic acids and proteins
AU2003220067A8 (en) Jade nucleic acids, proteins and uses thereof
AU2003218225A8 (en) Posh nucleic acids, polypeptides and related methods
AU2003258658A1 (en) Improved dna and proteins
EP1428877A4 (en) Novel protein and dna thereof
EP1492807A4 (en) Novel proteins and nucleic acids encoding same
AU2002365918A1 (en) Abca8 nucleic acids and proteins, and uses thereof
GB0201744D0 (en) Peptides nucleic acids and uses thereof
GB0214660D0 (en) Peptides nucleic acids and uses thereof
AU2003272339A1 (en) Virulence-associated nucleic acids and proteins and uses thereof
AU2003304707A1 (en) Novel nucleic acids and polypeptides

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase